Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Calciphylaxis: a pseudo-vasculitis syndrome.

Vasileios C Kyttaris1, Sukran Timbil, Dimitrios Kalliabakos

  • 1Section of Rheumatology, Washington Hospital Center, Washington, DC, USA. vkyttari@bidmc.harvard.edu <vkyttari@bidmc.harvard.edu>

Seminars in Arthritis and Rheumatism
|February 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical utility of a multianalyte lupus risk score incorporating cell-bound complement activation products: a systematic evaluation.

Lupus science & medicine·2026
Same author

Extracellular heme:DNA complexes promote oxidative stress and inflammation during lupus-associated hemolysis.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

IL-17<sup>+</sup>/IL-10<sup>+</sup> Ratio in TCRαβ<sup>+</sup> CD4<sup>-</sup> CD8<sup>-</sup> T Cells As a Marker of Disease Activity in Lupus-Prone Mice and Patients With Systemic Lupus Erythematosus.

ACR open rheumatology·2025
Same author

Discontinuation versus continuation of maintenance treatment with tumor necrosis factor inhibitors in patients with rheumatoid arthritis with low disease activity or remission: A randomized double-blind placebo-controlled trial.

Seminars in arthritis and rheumatism·2025
Same author

Advances in the treatment of systemic lupus erythematosus.

Nature reviews. Drug discovery·2025
Same author

Gluconolactone restores immune regulation and alleviates skin inflammation in lupus-prone mice and in patients with cutaneous lupus.

Science translational medicine·2025

Calciphylaxis, a rare condition in chronic renal disease patients, can mimic vasculitis. Early skin biopsy is crucial for accurate diagnosis and appropriate treatment, especially in end-stage renal disease.

Area of Science:

  • Nephrology
  • Dermatology
  • Pathology

Background:

  • Calciphylaxis is an uncommon but severe condition associated with chronic renal disease and calcium metabolism disorders.
  • It often presents with painful skin lesions that can be mistaken for vasculitis.
  • This case highlights the diagnostic challenges and clinical course of calciphylaxis.

Observation:

  • A patient with end-stage renal disease presented with severe lower extremity ulcers and upper extremity skin lesions.
  • Skin biopsy revealed calciphylaxis, distinct from vasculitis.
  • The patient experienced a fatal outcome following surgical intervention.

Findings:

  • Calciphylaxis diagnosis requires a high index of suspicion in patients with chronic kidney disease and relevant symptoms.

Related Experiment Videos

  • Skin biopsy is essential to differentiate calciphylaxis from vasculitis and other vascular diseases.
  • The condition carries a poor prognosis, as exemplified by this case.
  • Implications:

    • Calciphylaxis should be included in the differential diagnosis for patients presenting with vasculitic skin lesions, particularly those with renal impairment.
    • Prompt diagnosis via skin biopsy is critical to guide management and avoid potentially detrimental therapies like corticosteroids.
    • This case underscores the importance of early recognition and multidisciplinary management for improving patient outcomes in calciphylaxis.